Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,603 | 497 | 99.3% |
| Education | $57.82 | 4 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,287 | 78 | $0 (2024) |
| ABBVIE INC. | $1,263 | 71 | $0 (2024) |
| PFIZER INC. | $996.98 | 64 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $639.67 | 40 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $584.91 | 27 | $0 (2024) |
| Amgen Inc. | $469.52 | 24 | $0 (2024) |
| Lilly USA, LLC | $388.43 | 25 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $365.70 | 22 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $336.33 | 20 | $0 (2024) |
| Allergan, Inc. | $282.18 | 20 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,071 | 50 | PFIZER INC. ($175.37) |
| 2023 | $1,023 | 50 | Novo Nordisk Inc ($210.22) |
| 2022 | $988.78 | 55 | Novo Nordisk Inc ($177.71) |
| 2021 | $1,176 | 66 | AbbVie Inc. ($415.57) |
| 2020 | $758.49 | 46 | Novo Nordisk Inc ($137.91) |
| 2019 | $1,035 | 64 | PFIZER INC. ($167.98) |
| 2018 | $1,256 | 77 | Novo Nordisk Inc ($294.21) |
| 2017 | $1,353 | 93 | AbbVie, Inc. ($216.76) |
All Payment Transactions
501 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $27.57 | General |
| Category: DIABETES | ||||||
| 12/13/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.23 | General |
| Category: Obesity | ||||||
| 11/15/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: Obesity | ||||||
| 11/14/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: Neuromodulation | ||||||
| 11/02/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $25.03 | General |
| Category: Respiratory | ||||||
| 10/28/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $31.47 | General |
| Category: DIABETES | ||||||
| 10/16/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $23.28 | General |
| Category: Diabetes | ||||||
| 10/07/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $27.38 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/02/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $23.60 | General |
| Category: Respiratory | ||||||
| 09/25/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $24.18 | General |
| Category: Inflammation | ||||||
| 09/19/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 09/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $22.27 | General |
| Category: Gastroenterology | ||||||
| 09/11/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $26.52 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/03/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.29 | General |
| Category: Diabetes | ||||||
| 08/28/2024 | PFIZER INC. | PREVNAR 20 (Biological) | Food and Beverage | In-kind items and services | $21.42 | General |
| Category: VACCINES | ||||||
| 08/28/2024 | PFIZER INC. | PREVNAR 20 (Biological) | Food and Beverage | In-kind items and services | $0.40 | General |
| Category: VACCINES | ||||||
| 08/07/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: Oncology | ||||||
| 08/02/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $21.53 | General |
| Category: NEUROSCIENCE | ||||||
| 08/01/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.75 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/24/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $24.08 | General |
| Category: Obesity | ||||||
| 07/10/2024 | PFIZER INC. | PREVNAR 20 (Biological) | Food and Beverage | In-kind items and services | $27.88 | General |
| Category: VACCINES | ||||||
| 07/09/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $24.66 | General |
| Category: Inflammation/Rare Disease | ||||||
| 06/24/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $21.02 | General |
| Category: Bone Health | ||||||
| 06/24/2024 | Amgen Inc. | — | Education | In-kind items and services | $13.89 | General |
| 06/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $29.21 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,612 | 2,121 | $460,244 | $168,168 |
| 2022 | 13 | 1,243 | 1,823 | $398,359 | $141,981 |
| 2021 | 12 | 1,108 | 1,527 | $358,045 | $139,246 |
| 2020 | 10 | 991 | 1,387 | $320,570 | $104,562 |
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 308 | 640 | $194,560 | $64,370 | 33.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 255 | 255 | $91,290 | $36,924 | 40.4% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 63 | 63 | $41,706 | $17,803 | 42.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 169 | 251 | $51,706 | $17,059 | 33.0% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 28 | 30 | $19,650 | $7,116 | 36.2% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 70 | 70 | $11,620 | $5,231 | 45.0% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 208 | 208 | $10,608 | $4,418 | 41.6% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 19 | 19 | $8,778 | $3,512 | 40.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 78 | 79 | $5,767 | $2,736 | 47.4% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 12 | 13 | $6,032 | $2,390 | 39.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 63 | 63 | $4,599 | $2,182 | 47.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 143 | 204 | $2,012 | $1,673 | 83.1% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 20 | 25 | $3,775 | $1,180 | 31.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 77 | 83 | $5,561 | $881.72 | 15.9% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 70 | 87 | $1,392 | $385.05 | 27.7% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 18 | 20 | $660.00 | $190.40 | 28.8% |
| G0403 | Electrocardiogram, routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report | Office | 2023 | 11 | 11 | $528.00 | $118.44 | 22.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 235 | 486 | $147,744 | $49,858 | 33.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 261 | 261 | $93,068 | $39,005 | 41.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 271 | 485 | $99,910 | $32,840 | 32.9% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 23 | 29 | $18,995 | $7,204 | 37.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 50 | 51 | $8,313 | $3,492 | 42.0% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 15 | 16 | $7,424 | $2,532 | 34.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 62 | 63 | $4,599 | $2,184 | 47.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 11 | 11 | $4,455 | $1,806 | 40.5% |
About Dr. Barbara Yosaitis, M.D
Dr. Barbara Yosaitis, M.D is a Internal Medicine healthcare provider based in Fairfax, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/19/2007. The National Provider Identifier (NPI) number assigned to this provider is 1679617997.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Barbara Yosaitis, M.D has received a total of $8,661 in payments from pharmaceutical and medical device companies, with $1,071 received in 2024. These payments were reported across 501 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($8,603).
As a Medicare-enrolled provider, Yosaitis has provided services to 4,954 Medicare beneficiaries, totaling 6,858 services with total Medicare billing of $553,957. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Fairfax, VA
- Active Since 02/19/2007
- Last Updated 05/21/2008
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1679617997
Products in Payments
- Ozempic (Drug) $541.32
- JARDIANCE (Drug) $465.98
- UBRELVY (Drug) $412.22
- FARXIGA (Drug) $411.52
- SYNTHROID (Drug) $333.00
- XARELTO (Drug) $295.20
- ELIQUIS (Drug) $269.51
- Synthroid (Drug) $243.53
- Saxenda (Drug) $219.44
- CHANTIX (Drug) $202.43
- SOLIQUA 100/33 (Biological) $193.04
- Rybelsus (Drug) $192.28
- NURTEC ODT (Drug) $180.68
- TRULICITY (Drug) $160.65
- JANUVIA (Drug) $148.65
- Wegovy (Drug) $144.93
- Trintellix (Drug) $138.08
- VRAYLAR (Drug) $137.32
- TRADJENTA (Drug) $137.20
- PREVNAR - 13 (Biological) $132.98
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Fairfax
Samim Enayat, Md, MD
Internal Medicine — Payments: $437,610
Brett Atwater, M.d, M.D
Internal Medicine — Payments: $355,531
Kathleen Harnden, M.d, M.D
Internal Medicine — Payments: $173,063
Dr. Daniel Kim, M.d., M.b.a, M.D., M.B.A
Internal Medicine — Payments: $124,814
Dr. Reza Zonozi, M.d, M.D
Internal Medicine — Payments: $118,319
Dr. Elizabeth Held, M.d, M.D
Internal Medicine — Payments: $84,557